Khiron Life Sciences Stock Fundamentals
| 4KH Stock | 0.02 0.00 0.00% |
Khiron Life Sciences fundamentals help investors to digest information that contributes to Khiron Life's financial success or failures. It also enables traders to predict the movement of Khiron Stock. The fundamental analysis module provides a way to measure Khiron Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Khiron Life stock.
Khiron |
Khiron Life Sciences Company EBITDA Analysis
Khiron Life's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Khiron Life EBITDA | (32.03 M) |
Most of Khiron Life's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Khiron Life Sciences reported earnings before interest,tax, depreciation and amortization of (32.03 Million). This is much lower than that of the sector and significantly lower than that of the EBITDA industry. The ebitda for all Germany stocks is notably higher than that of the company.
Khiron Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.Khiron Life Sciences is rated fifth in current valuation category among its peers. It is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Khiron Life Sciences is about 22,225,088 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Khiron Life's earnings, one of the primary drivers of an investment's value.Khiron EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Khiron Life's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Khiron Life could also be used in its relative valuation, which is a method of valuing Khiron Life by comparing valuation metrics of similar companies.Khiron Life is currently under evaluation in ebitda category among its peers.
Khiron Fundamentals
| Current Valuation | 8.72 M | |||
| Price To Book | 0.39 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 12.79 M | |||
| EBITDA | (32.03 M) | |||
| Net Income | (33.13 M) | |||
| Total Debt | 705 K | |||
| Cash Flow From Operations | (20.4 M) | |||
| Market Capitalization | 27.46 M | |||
| Total Asset | 42.27 M | |||
| Z Score | 22.8 | |||
| Net Asset | 42.27 M |
About Khiron Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Khiron Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Khiron Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Khiron Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Khiron Stock Analysis
When running Khiron Life's price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.